Gene · 80331
NIH grants1,608
NIH grants whose papers are about the gene, through NIH's grant-paper links.
821 to 840 of 1,608
Download this page as JSON| Grant | Title | DNAJC5 papers | Newest fiscal year |
|---|---|---|---|
| R01AG043375 | Cellular and Molecular Medial Temporal Lobe Pathology in Elderly PreMCI subjects | 2 | 2017 |
| R01AI102891 | Mechanisms of induction of protective anti-malarial CD8+ T Cells | 2 | 2017 |
| R37AI042767 | Regulation of primary and secondary CD4 and CD8 T cell memory | 2 | 2017 |
| D43TW007391 | Tsetse Transmitted African Trypanosomiasis | 1 | 2017 |
| DP2AI138239 | Enabling Host Processes for Defense Against Liver Stage Malaria Infection | 1 | 2017 |
| DP5OD017898 | Targeting Tumors with Resealable Nanovesicles Permeabilized by NIR Light | 1 | 2017 |
| F31AI118244 | Understanding cellular interactions and the immunobiology of the malaria liver stage | 1 | 2017 |
| F32AI112271 | Post-transcriptional regulation in the malaria parasite blood stage | 1 | 2017 |
| F32CA200103 | Blocking an Endogenous Inhibitor of Anti-tumor Leukocyte Recruitment | 1 | 2017 |
| F32DK107164 | The role of innate immune response in HBV infection and persistence | 1 | 2017 |
| F32GM122362 | Pairing Alkyl Radicals with Ni Catalysts: Elucidating Mechanism and Exploring New Reaction Methodology with Carboxylates | 1 | 2017 |
| G12MD007599 | Basic and Translational Research Center for Reducing Health Disparities | 1 | 2017 |
| I01BX001637 | Hsp70_DNAJ interface as a drug target for Alzheimers disease and TBI | 1 | 2017 |
| K01DK103823 | Mechanisms of Developmental Programing of beta-cell Susceptibility to Glucolipotoxicity | 1 | 2017 |
| K99HL133453 | Erythrocyte Subversion by Malaria Parasite Exported Effectors | 1 | 2017 |
| P01GM047467 | NMR and Computational Studies of Biomolecules | 1 | 2017 |
| P01GM066275 | Fundamental Studies of RNA Folding | 1 | 2017 |
| P01HD059454 | Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa | 1 | 2017 |
| P30GM103324 | COBRE Phase III: Transitional Center for Research on Processes in Evolution | 1 | 2017 |
| P50DA000266 | Drug Abuse Research Center | 1 | 2017 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80331/grants?page=42